NCT01670695 A Prospective Cohort Study of IgG4RD in China
| NCT ID | NCT01670695 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking Union Medical College Hospital |
| Condition | IgG4-related Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2012-01 |
| Primary Completion | 2032-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2012-01 with a primary completion date of 2032-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an cohort study to investigate the disease course and treatment response of patients with IgG4-related disease.
Eligibility Criteria
Inclusion Criteria: * Males and females * Age 18-75 years old with informed consent * Patients with IgG4-RD: 1. swelling, sclerosing and inflammatory involvement of one or more organ, including sclerosing pancreatitis, sclerosing cholangitis, inflammatory pseudotumors, retroperitoneal or mediastinal fibrosis, interstitial nephritis, hypophysitis, sclerosing dacryoadenitis, sialadenitis, inflammatory aortic aneurysm, lymphadenopathy, or other inflammatory conditions; 2. elevated serum IgG4 (\>1.35 g/L) 3. histopathologic features of fibrosis and/or lymphocytic and polyclonal plasma cell infiltration (and IgG4+ plasma cells on immunohistology when performed); 4. exclusion of other diseases. Exclusion Criteria: * Females planning to bear a child recently or with childbearing potential * Concurrent severe and/or uncontrolled and/or unstable diseases * Patient with malignancy
Contact & Investigator
Wen Zhang, MD
PRINCIPAL INVESTIGATOR
Deptment of Rheumatology, Peking Union Medical College Hospital
Frequently Asked Questions
Who can join the NCT01670695 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying IgG4-related Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01670695 currently recruiting?
Yes, NCT01670695 is actively recruiting participants. Contact the research team at chen77hua@gmail.com for enrollment information.
Where is the NCT01670695 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT01670695 clinical trial?
NCT01670695 is sponsored by Peking Union Medical College Hospital. The principal investigator is Wen Zhang, MD at Deptment of Rheumatology, Peking Union Medical College Hospital. The trial plans to enroll 1,000 participants.